Healthcare Touched New Highs: Taro Pharmaceutical Industries (NYSE:TARO), Inogen (NASDAQ:INGN), Health Net (NYSE:HNT)

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) continued to lead the category in 2013 with a retail value share of 25% thanks to brands such as Tarodent and Anadent, which held shares of 22% and 3%, respectively. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) stock performance was 16.65% in last session and finished the day at $137.97. Traded volume was 227,446.00million shares in the last session and the average volume of the stock remained 51.5K shares. The beta of the stock remained 0.47. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) insider ownership is 65.84%.

Inogen Inc. (NASDAQ:INGN) announced Tuesday that it has received FDA clearance for home oxygen concentrator called the Inogen At Home. According to the company, the Inogen At Home is expected to be the lightest 5 liter per minute continuous flow oxygen concentrator on the market, when it is released for sale later this year.  Inogen Inc (NASDAQ:INGN) rose 6.01 percent to $21.75 Friday on volume of 159,712.00million shares. The intra-day range of the stock was $20.49 to $22.03. Inogen Inc (NASDAQ:INGN) has a market capitalization of $397.69million.

The rise and fall of health care Net Inc. (NYSE:HNT) stocks is often hard to grasp, particularly in a world where the health care laws are creating some large potential winners and losers. Many investors guessed that health care stocks and insurance providers would be crushed under the Affordable Care Act (ACA), or Obamacare, but now some of the companies have seen their stocks hit new highs. Health Net, Inc. (NYSE:HNT)’s stock on June 27, 2014 reported a increase of 2.88% to the closing price of $41.84. Its fifty two weeks range is $25.40 -$42.33. The total market capitalization recorded $3.36billion. The overall volume in the last trading session was 1.27million shares. In its share capital, HNT has 80.20million outstanding shares.